Brazil Contraceptive Devices Market Report is Segmented by Type (Condoms, Diaphragms and Cervical Caps, Vaginal Sponges, Vaginal Rings, Intra-Uterine Devices (IUD), Subdermal Implants and More), and Gender (Male, Female), Material (Latex and Non- Latex) and Distribution Channel (Public Health System, Hospital Pharmacies, Retail Pharmacies & Drugstores and More). The Market Forecasts are Provided in Terms of Value (USD).

The size of the Contraceptive Devices Market was valued at USD 7,013.8 Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of XXX% during the forecast period. Recent developments include: July 2021 - Medicines and Healthcare Products Regulatory Agency (MHRA) announced that progestogen-only contraceptive pills will be available to purchase without prescription from pharmacies after consulting pharmacist., April 2021 - Mayne Pharma Group Limited and Mithra Pharmaceuticals announced the approval by U.S Food and Drug Administration (FDA) for oral contraceptive NEXTSTELLIS. It is the only contraceptive pill containing estetrol, which is produced from a plant source., January 2021 - Teva Pharmaceuticals API, announced the availability of a generic version of NuvaRing which is an estrogen/progestin combination hormonal contraceptive (CHC) directed to be used by women to prevent pregnancy..

Discover Market Research Intellect's Contraceptive Devices Market Report, worth USD 15.67 billion in 2024 and projected to hit USD 25.73 billion by 2033, registering a CAGR of 6.5% between 2026 and 2033.Gain in-depth knowledge of emerging trends, growth drivers, and leading companies.

The global contraceptive devices market size attained a value of about USD 11.57 Billion in 2024. The market is anticipated to grow further at a CAGR of 6.60% during the forecast period of 2025-2034 to attain a value of USD 21.92 Billion by 2034.

The Canada Contraceptive Devices Market Report is Segmented by Type (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, Intra Uterine Devices (IUDs), and Other Types) and Gender (Male and Female). The market size and forecast values are provided in terms of (USD) for all the above segments.

The Contraceptive Devices Market size was valued at USD 2.6 Billion in 2024 and is projected to reach USD 5.05 Billion by 2032, growing at a CAGR of 6.2% from 2026 to 2032.

Global Contraceptive Devices Market Definition

Contraceptive devices are items that are used to prevent unintended pregnancies from occurring. The devices function as a barrier between the sperm and the ovum, inducing modifications in the ovulation mechanism in the female reproductive system. Contraception includes a variety of devices that are used to prevent pregnancy, including intrauterine devices [IUD], condoms, diaphragms, sponges, patches, implants, vaginal rings, and other devices. While preventing unwanted pregnancies continues to be one of the most important reasons for the use of Contraceptive Devices, the other important function of a wide variety of Contraceptive Devices is to prevent the transmission of sexually transmitted diseases or infections, which is a growing concern.

The contraceptive devices market size was over USD 11.4 billion in 2025 and is estimated to reach USD 17.6 billion by the end of 2035, expanding at a CAGR of 5% during the forecast timeline, i.e., 2026-2035. North America industry is predicted to account for the largest share of 50.1% by 2035, owing to well-developed healthcare facilities in the region.

Contraceptive Devices Market Outlook

The global contraceptive devices market size was estimated at USD 11.3 billion in 2023 and is projected to reach USD 18.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.6% from 2024 to 2032. The growth of this market is propelled by increasing awareness regarding family planning and the prevention of sexually transmitted infections (STIs), which is fueling the demand for effective contraceptive solutions. Contraceptive devices play a crucial role in empowering individuals to make informed choices about their reproductive health, and their adoption is steadily increasing across various demographics and regions.

One of the primary growth factors in the contraceptive devices market is the rising global population, which necessitates improved birth control measures. Rapid urbanization and the consequential shift in societal norms have further emphasized the importance of family planning. Governments and non-governmental organizations (NGOs) around the world are actively promoting the use of contraceptives to manage population growth and reduce the burden on healthcare systems. Additionally, increased funding for family planning programs and initiatives focusing on reproductive health education are enhancing the accessibility and availability of contraceptive devices, thereby driving market growth.

The technological advancements in contraceptive devices are another significant contributor to market expansion. Innovations such as the development of hormone-free devices, long-acting reversible contraceptives (LARCs), and user-friendly application methods are attracting a broader consumer base. These advancements not only improve the efficacy and safety of contraceptive devices but also address the concerns associated with traditional methods, such as side effects and ease of use. Moreover, the integration of smart technology in contraceptive devices, providing features like reminders and tracking applications, is resonating well with tech-savvy consumers, further propelling market growth.

Socio-economic factors also play a pivotal role in the growth of the contraceptive devices market. The increasing participation of women in the workforce, coupled with a rise in educational attainment levels, is contributing to the increased demand for contraceptive solutions. Women are seeking greater control over their reproductive health, leading to a higher adoption rate of contraceptive devices. Furthermore, the reduction in stigma surrounding the use of contraceptives in many regions has created a more favorable environment for market growth, with more individuals willing to discuss and access these essential healthcare products.

Regionally, the contraceptive devices market exhibits varied growth patterns. North America holds a significant share due to the high awareness and accessibility of contraceptive methods, along with robust healthcare infrastructure. Europe follows suit with supportive governmental policies promoting reproductive health. The Asia Pacific region is anticipated to witness the highest growth rate, driven by large population bases, increasing disposable incomes, and progressive governmental initiatives aimed at enhancing family planning services. Latin America and the Middle East & Africa, while currently holding smaller market shares, present significant growth opportunities as awareness and accessibility improve over the forecast period.

Product Type Analysis

The contraceptive devices market is segmented into various product types, including condoms, diaphragms, cervical caps, sponges, vaginal rings, intrauterine devices (IUDs), and others. Condoms remain the most widely used contraceptive device globally, owing to their dual protection against pregnancy and sexually transmitted infections (STIs). The demand for condoms is supported by strong promotional campaigns and increased availability in retail channels. Moreover, innovations in material technology, such as the use of latex alternatives, are enhancing their appeal to individuals with allergies, further driving their market share.

Intrauterine devices (IUDs) have gained significant popularity due to their high efficacy and long-term contraceptive benefits. IUDs are particularly appealing to women seeking low-maintenance birth control options, and their market growth is bolstered by favorable healthcare policies and increased awareness campaigns. The introduction of hormone-releasing IUDs has also expanded their consumer base, offering additional benefits such as reduced menstrual bleeding. With ongoing research and development, the IUD segm

UK Contraceptive Devices Market Report is Segmented by Type (Condoms, Diaphragms & Cervical Caps, Vaginal Rings, Intra Uterine Devices, Implants & Injectables, Spermicidal Devices and Other Types), Gender (Male and Female) and Distribution Channel (NHS & Community Sexual-Health Clinics, Retail Pharmacies, Online Pharmacies & E-Commerce, and More). The Market Forecasts are Provided in Terms of Value (USD).

The global contraceptive devices market size reached USD 15.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 23.1 Billion by 2033, exhibiting a growth rate (CAGR) of 4.9% during 2025-2033. The increasing awareness about the importance of family planning, the growing incidence of unintended pregnancies, and the rising government initiatives and funding to promote family planning programs represent some of the key factors driving the market.

IMARC Group provides an analysis of the key trends in each sub-segment of the global contraceptive devices market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on device type, end user and distribution channel.

Contraceptive Devices Market Outlook

According to our latest research, the contraceptive devices market size reached USD 12.8 billion globally in 2024, reflecting a robust demand for effective family planning solutions. The market is experiencing a compound annual growth rate (CAGR) of 6.3%, driven by rising awareness, government initiatives, and technological advancements. By 2033, the market is forecasted to attain a value of USD 22.1 billion, as increasing population, changing societal norms, and a growing focus on women’s health continue to fuel adoption. This growth trajectory highlights the critical role contraceptive devices play in global public health and underscores the ongoing innovation within the sector.

Several key growth factors are propelling the expansion of the contraceptive devices market. First and foremost, heightened awareness regarding reproductive health and family planning is significantly influencing consumer behavior, particularly in emerging economies. Governments and non-governmental organizations are actively promoting contraceptive use through educational campaigns and subsidized distribution, which in turn increases accessibility and acceptance. Furthermore, the rise in the global population, coupled with urbanization and changing lifestyles, has led to a greater need for effective birth control methods. These socio-demographic trends are compelling manufacturers to innovate and diversify their product offerings, ensuring that modern contraceptive devices are safer, more effective, and easier to use.

Technological advancements have also played a pivotal role in shaping the contraceptive devices market. The introduction of next-generation products, such as long-acting reversible contraceptives (LARCs), hormone-releasing intrauterine devices (IUDs), and male contraceptive devices, has transformed the landscape. These innovations offer higher efficacy, convenience, and fewer side effects compared to traditional methods. Additionally, research and development investments are yielding novel devices that cater to the specific needs of various user groups, including adolescents, postpartum women, and men. The integration of digital health technologies, such as mobile apps for tracking fertility and device usage, further enhances user experience and compliance, contributing to overall market growth.

The contraceptive devices market is also benefiting from favorable policy frameworks and increasing healthcare expenditure worldwide. Many countries have incorporated reproductive health services into their national healthcare agendas, ensuring that contraceptive devices are included in essential healthcare packages. This policy support, combined with improved healthcare infrastructure and rising disposable incomes, is facilitating greater market penetration. Private sector participation, along with strategic collaborations between manufacturers, healthcare providers, and governments, is further accelerating the distribution and adoption of contraceptive devices. These collective efforts are expected to sustain the market’s upward trajectory in the coming years.

From a regional perspective, North America and Europe currently dominate the contraceptive devices market, accounting for a significant share of global revenues. However, the Asia Pacific region is emerging as a high-growth market, driven by large population bases, increasing awareness, and government-led family planning initiatives. Latin America and the Middle East & Africa are also witnessing steady growth, albeit from a smaller base, as cultural barriers gradually diminish and access to healthcare improves. The regional outlook suggests that while mature markets will continue to innovate and expand, the bulk of future growth will be driven by emerging economies, where unmet needs for contraception remain substantial.

Product Type Analysis

The contraceptive devices market is segmented by product type into male contraceptive devices and female contraceptive devices, each exh

For 2024, the contraceptive devices market in the United States was estimated at around five billion U.S. dollars. This statistic presents forecasts of the contraceptive devices market in the U.S. for 2024 and 2029.

The Market is Segmented by Type (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, Intra Uterine Devices (IUD), and Implants) and Gender

The global intrauterine contraceptive devices market size is projected to grow from USD 3.21 billion in 2025 to USD 4.23 billion by 2033, exhibiting a CAGR of 3.5%.
Report Scope:

United States Contraceptive Devices Market valued at USD 5.4 billion, driven by reproductive health awareness, government initiatives, and tech advancements in IUDs and implants.

The China contraceptive devices market, valued at $711.73 million in 2025, is projected to experience robust growth, exhibiting a Compound Annual Growth Rate (CAGR) of 6.10% from 2025 to 2033. This expansion is fueled by several key drivers. Rising awareness of family planning and reproductive health, particularly amongst younger generations, is a significant factor. Government initiatives promoting family planning and access to contraception, alongside increasing urbanization and improved access to healthcare services, are also contributing to market growth. Furthermore, evolving societal attitudes towards sexual health and a shift towards smaller family sizes are creating increased demand. Key market trends include the growing popularity of convenient and discreet contraceptive methods, such as condoms and female sterilization methods, and the increasing demand for higher-quality, more effective products. However, the market faces certain restraints. These include lingering social stigmas associated with contraception in certain regions, limited access to comprehensive sexual education and reproductive healthcare services in rural areas, and concerns about the affordability and accessibility of certain contraceptive methods, particularly among lower-income populations. The market is segmented by product type (condoms, diaphragms, intrauterine devices (IUDs), and other product types) and end-user (male and female). Leading players in the market include international corporations like Teva Pharmaceutical Industries Ltd, Bayer Healthcare, Reckitt Benckiser, and Okamoto, alongside domestic manufacturers such as Guangzhou Iclear Healthcare Limited and Shandong Ming Yuan Latex Co Ltd. Competitive dynamics are shaped by a mix of established multinational companies leveraging brand recognition and advanced product offerings, and domestic firms focusing on cost-effective solutions and catering to specific regional demands. The competitive landscape is further characterized by ongoing innovation in product development, with companies focusing on improving efficacy, safety, and user convenience. The introduction of new contraceptive technologies, such as long-acting reversible contraceptives (LARCs) like IUDs and implants, is expected to drive future market growth. However, the regulatory environment and stringent quality control standards in China represent a significant challenge for market entrants. Regional variations in access to healthcare and contraceptive awareness also present a complex distribution network for companies to navigate effectively. Future market growth will depend significantly on continued government support for family planning programs, successful public health campaigns aimed at increasing awareness and reducing social stigma, and the sustained expansion of healthcare infrastructure, particularly in underserved rural areas. The strategic focus of major players will likely involve expanding distribution networks, investing in research and development of innovative products, and tailoring their marketing efforts to address specific regional needs and preferences. The historical period (2019-2024) provides a baseline for understanding past market performance and informing future projections. This report provides a detailed analysis of the China contraceptive devices market, encompassing market size, segmentation, trends, key players, and future growth prospects. The market is estimated to be worth several million units annually, with significant variations across product types and end-users. Recent developments include: In February 2022, the Government of China began an online propaganda campaign focused on how to respect the social value of childbirth and advocate age-appropriate marriage and childbearing, as well as optimal child-bearing and raising. This campaign is expected to increase awareness about contraceptive devices in the country, which may boost the market's growth., In June 2021, DKT WomanCare and Shanghai Dahua Pharmaceutical announced the price reduction of their Levoplant contraceptive implant to USD 6.70, thus increasing the affordability of these devices., In April 2021, Daxiang, a Beijing-based condom company, announced that they had sued Durex for plagiarizing their copyright-protected "butter box" product design, which was registered as a patent by the brand.. Key drivers for this market are: Rising Cases of Sexually Transmitted Diseases, Government Initiatives Regarding the Usage of Contraceptive Devices. Potential restraints include: Side Effects Associated with Contraceptive Devices. Notable trends are: Intrauterine Devices are Expected to Hold a Significant Share in the Market During the Forecast Period.

United States Contraceptives Devices Market Outlook 2031:

The United States contraceptives devices market size was valued at USD 4.56 Billion in 2022 and is projected to reach USD 7.66 Billion by 2031, expanding at a CAGR of 5.93% during the forecast period 2023 - 2031. The growth of the market is attributed to the reduced unplanned pregnancies and their consequences.



Contraceptives device aids in preventing pregnancy by using drugs or devices. It is also known as birth control and fertility control devices. Increasing use of contraceptives at home has improved health related outcomes. Robust government promotions and schemes for women and child health is driving the market growth.

These devices are used to prevent transfer of sexually transmitted diseases or infections. Contraceptive devices could be temporary or permanent and are available for both men as well as women. Condoms are most preferred contraceptive devices and hold a large market share in the world. Copper IUD is basically used by the women to avoid possible side effects.



Bayer HealthCare collaborated with 11 NGOs, which in turn, led to increase of its share in the contraceptives devices market. Every year on September 26, “World Contraception Day” is celebrated to increase awareness about contraceptive methods, and encourage young people to make right decision about their reproductive health.

Contraceptives Devices Market Trends, Drivers, Restraints, and Opportunities

• Increasing population is anticipated to drive the market growth during the forecast period.


• Rising use of

The size of the France Contraceptive Devices Market market was valued at USD 458.16 Million in 2023 and is projected to reach USD 707.31 Million by 2032, with an expected CAGR of 6.40% during the forecast period. Recent developments include: In January 2023, France began offering free condoms to anyone 25 and under to cut the number of unwanted pregnancies and sexually transmitted diseases., In September 2021, the French Health Minister announced that France would offer free hormonal contraception pills and intrauterine devices to all women up to age 25 from January 2022. The measure will also include free medical visits about contraception. Previously, birth control was free for girls up to 18 years old, but now it has been expanded to all women up to 25.. Key drivers for this market are: Increasing Awareness About Sexually Transmitted Diseases (STDs), Rising Rate of Unintended Pregnancies and Government Initiatives. Potential restraints include: Side Effects Associated with the Use of Contraceptive Devices. Notable trends are: Condoms are Expected to Dominate the Contraceptive Devices Market Over the Forecast Period.

Japan Contraceptive Devices Market size was valued at USD 1.25 Billion in 2024 and is projected to reach USD 1.78 Billion by 2031, growing at a CAGR of 4.5% from 2026 to 2032.

Key Market Drivers

Increasing Late Marriage Trends and Career-Focused Lifestyle: The rising trend of late marriages in Japan, with the average age of first marriage reaching 31.0 years for men and 29.4 years for women in 2020—a nearly three-year increase since the 1990s, according to the Ministry of Health, Labour, and Welfare—reflects a career-focused lifestyle among working professionals, particularly in urban areas. This shift increases demand for dependable contraceptive devices as people prioritize their professions and personal ambitions over raising kids, needing effective family planning methods to avoid unwanted pregnancies during their peak working years.

Rising Awareness of Sexual Health Among Youth: Rising sexual health awareness among Japan’s youth has resulted in increased adoption of modern contraceptive methods, with the percentage of sexually active young adults (aged 18-34) using such methods increasing from 54.3% in 2010 to 62.1% in 2021, according to the National Institute of Population and Social Security Research.

Overview

New York, NY – Aug 14, 2025 – Global Contraceptive Devices Market size is expected to be worth around US$ 16.9 Billion by 2034 from US$ 10.6 Billion in 2024, growing at a CAGR of 4.8% during the forecast period 2025 to 2034. In 2024, North America led the market, achieving over 42.3% share with a revenue of US$ 4.5 Billion.

The global contraceptive devices market is experiencing steady growth, driven by rising awareness of family planning, government initiatives, and technological advancements in product design. Contraceptive devices, including male and female condoms, diaphragms, cervical caps, and intrauterine devices (IUDs), are increasingly being adopted as safe and effective methods for preventing unintended pregnancies.

The growth of the market can be attributed to factors such as increased public health campaigns, improved accessibility through healthcare facilities, and favorable reimbursement policies in several regions. Technological innovations have enhanced user convenience, reduced side effects, and improved efficacy rates, contributing to stronger consumer acceptance.

North America and Europe remain significant markets due to higher awareness levels and strong healthcare infrastructure, while the Asia-Pacific region is projected to witness the fastest growth, driven by expanding population bases, rising disposable incomes, and improving access to reproductive healthcare services.

Leading manufacturers are focusing on product diversification, collaborations with healthcare providers, and distribution network expansion to strengthen market presence. In addition, growing advocacy for women’s reproductive rights is creating a favorable environment for market expansion. With continued emphasis on preventive healthcare, the contraceptive devices market is expected to maintain a positive trajectory, providing safe, affordable, and accessible solutions for family planning and reproductive health worldwide.